{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T04:29:09Z","timestamp":1730348949298,"version":"3.28.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,30]]},"DOI":"10.7759\/cureus.72689","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:03:39Z","timestamp":1730300619000},"source":"Crossref","is-referenced-by-count":0,"title":["Two Case Reports of Zoledronic Acid-Induced Acute Anterior Uveitis"],"prefix":"10.7759","author":[{"given":"David Alexander","family":"Vernaza Trujillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola Milena","family":"Osorio Escorcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Sierra Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica Andrea","family":"Morales Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alin","family":"Abreu Lomba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2014.942747","article-title":"A case series and review of bisphosphonate-associated orbital inflammation","volume":"24","author":"Lefebvre DR","year":"2016","unstructured":"Lefebvre DR, Mandeville JT, Yonekawa Y, Arroyo JG, Torun N, Freitag SK. A case series and review of bisphosphonate-associated orbital inflammation. Ocul Immunol Inflamm. 2016, 24:134-9. 10.3109\/09273948.2014.942747","journal-title":"Ocul Immunol Inflamm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3109\/01676830.2015.1078380","article-title":"Bisphosphonate-induced orbital inflammation: A case series and review","volume":"34","author":"Pirbhai A","year":"2015","unstructured":"Pirbhai A, Rajak SN, Goold LA, et al.. Bisphosphonate-induced orbital inflammation: A case series and review. Orbit. 2015, 34:331-5. 10.3109\/01676830.2015.1078380","journal-title":"Orbit"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcreue.2019.01.004","article-title":"Second Colombian consensus on the management of postmenopausal osteoporosis","volume":"25","author":"Medina Orjuela A","year":"2018","unstructured":"Medina Orjuela A, Rosero Olarte \u00d3, Nel Rueda Plata P, et al.. Second Colombian consensus on the management of postmenopausal osteoporosis. Rev Colomb Reumatol. 2018, 25:184-210. 10.1016\/j.rcreue.2019.01.004","journal-title":"Rev Colomb Reumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-015-0015-4","article-title":"The effects of re-challenge in patients with a history of acute anterior uveitis following intravenous zoledronate","volume":"97","author":"Patel DV","year":"2015","unstructured":"Patel DV, Horne A, Mihov B, Stewart A, Reid IR, McGhee CN. The effects of re-challenge in patients with a history of acute anterior uveitis following intravenous zoledronate. Calcif Tissue Int. 2015, 97:58-61. 10.1007\/s00223-015-0015-4","journal-title":"Calcif Tissue Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa048","article-title":"Pharmacological management of osteoporosis in postmenopausal women: An Endocrine Society guideline update","volume":"105","author":"Shoback D","year":"2020","unstructured":"Shoback D, Rosen CJ, Black DM, Cheung AM, Murad MH, Eastell R. Pharmacological management of osteoporosis in postmenopausal women: An Endocrine Society guideline update. J Clin Endocrinol Metab. 2020, 105:10.1210\/clinem\/dgaa048","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff MS","year":"2022","unstructured":"LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, Siris ES. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022, 33:2049-102. 10.1007\/s00198-021-05900-y","journal-title":"Osteoporos Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcreu.2016.06.002","article-title":"Possible ocular adverse effects attributable to bisphosphonate therapy: Two case reports","volume":"24","author":"G\u00f3mez Escobar LG","year":"20171","unstructured":"G\u00f3mez Escobar LG, Gonz\u00e1lez Devia D. Possible ocular adverse effects attributable to bisphosphonate therapy: Two case reports. Rev Colomb Reumatol. 20171, 24:54-59. 10.1016\/j.rcreu.2016.06.002","journal-title":"Rev Colomb Reumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1654_19","article-title":"Zoledronic acid induced unilateral anterior uveitis","volume":"68","author":"Gupta S","year":"2020","unstructured":"Gupta S, Onkar A, Vashisht T. Zoledronic acid induced unilateral anterior uveitis. Indian J Ophthalmol. 2020, 68:2002-3. 10.4103\/ijo.IJO_1654_19","journal-title":"Indian J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_2685_22","article-title":"Zoledronic acid-induced sclerokeratouveitis in a patient with metastatic breast carcinoma","volume":"3","author":"Joji A","year":"2023","unstructured":"Joji A, Thomas R, Gupta R. Zoledronic acid-induced sclerokeratouveitis in a patient with metastatic breast carcinoma. Indian J Ophthalmol. 2023, 3:990-993. 10.4103\/IJO.IJO_2685_22","journal-title":"Indian J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afy070","article-title":"Two case reports of zoledronic acid-induced uveitis","volume":"47","author":"Kennedy T","year":"2018","unstructured":"Kennedy T, Sellar PW, Vaideanu-Collins D, Ng J. Two case reports of zoledronic acid-induced uveitis. Age Ageing. 2018, 47:754-5. 10.1093\/ageing\/afy070","journal-title":"Age Ageing"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-007-9006-2","article-title":"A case report: Zoledronic acid-induced anterior uveitis","volume":"25","author":"Kilickap S","year":"2008","unstructured":"Kilickap S, Ozdamar Y, Altundag MK, Dizdar O. A case report: Zoledronic acid-induced anterior uveitis. Med Oncol. 2008, 25:238-40. 10.1007\/s12032-007-9006-2","journal-title":"Med Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2006.04.013","article-title":"Serious ocular complications of zoledronate","volume":"18","author":"Woo TC","year":"2006","unstructured":"Woo TC, Joseph DJ, Wilkinson R. Serious ocular complications of zoledronate. Clin Oncol (R Coll Radiol). 2006, 18:545-6. 10.1016\/j.clon.2006.04.013","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5693\/djo.02.2017.08.002","article-title":"Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature","volume":"23","author":"Umunakwe OC","year":"2017","unstructured":"Umunakwe OC, Herren D, Kim SJ, Kohanim S. Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature. Digit J Ophthalmol. 2017, 23:18-21. 10.5693\/djo.02.2017.08.002","journal-title":"Digit J Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/01.icu.0000434534.32063.5c","article-title":"Drug-induced uveitis","volume":"24","author":"Moorthy RS","year":"2013","unstructured":"Moorthy RS, London NJ, Garg SJ, Cunningham ET Jr. Drug-induced uveitis. Curr Opin Ophthalmol. 2013, 24:589-97. 10.1097\/01.icu.0000434534.32063.5c","journal-title":"Curr Opin Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18502\/jovr.v17i1.10176","article-title":"Orbital inflammation caused by aminobisphosphonates","volume":"17","author":"Gonzalez Barlatay J","year":"2022","unstructured":"Gonzalez Barlatay J, Pagano Boza C, Hernandez Gauna GV, Premoli JE. Orbital inflammation caused by aminobisphosphonates. J Ophthalmic Vis Res. 2022, 17:118-22. 10.18502\/jovr.v17i1.10176","journal-title":"J Ophthalmic Vis Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.10.028","article-title":"The incidence of acute anterior uveitis after intravenous zoledronate","volume":"120","author":"Patel DV","year":"2013","unstructured":"Patel DV, Horne A, House M, Reid IR, McGhee CN. The incidence of acute anterior uveitis after intravenous zoledronate. Ophthalmology. 2013, 120:773-6. 10.1016\/j.ophtha.2012.10.028","journal-title":"Ophthalmology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1783","article-title":"Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: Cohort analysis using a national prescription database","volume":"28","author":"Pazianas M","year":"2013","unstructured":"Pazianas M, Clark EM, Eiken PA, Brixen K, Abrahamsen B. Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: Cohort analysis using a national prescription database. J Bone Miner Res. 2013, 28:455-63. 10.1002\/jbmr.1783","journal-title":"J Bone Miner Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102454","article-title":"Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO's pharmacovigilance database","volume":"111","author":"Anquetil C","year":"2020","unstructured":"Anquetil C, Salem JE, Lebrun-Vignes B, et al.. Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO's pharmacovigilance database. J Autoimmun. 2020, 111:102454. 10.1016\/j.jaut.2020.102454","journal-title":"J Autoimmun"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001503","article-title":"Uveitis, a rare but important complication of adjuvant zoledronic acid for early-stage breast cancer","volume":"34","author":"Chacko G","year":"2023","unstructured":"Chacko G, Kota S, Kumar S, et al.. Uveitis, a rare but important complication of adjuvant zoledronic acid for early-stage breast cancer. Anticancer Drugs. 2023, 34:592-4. 10.1097\/CAD.0000000000001503","journal-title":"Anticancer Drugs"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/09273940902916111","article-title":"Anterior uveitis complicating zoledronic acid infusion","volume":"17","author":"Colucci A","year":"2009","unstructured":"Colucci A, Modorati G, Miserocchi E, Di Matteo F, Rama P. Anterior uveitis complicating zoledronic acid infusion. Ocul Immunol Inflamm. 2009, 17:267-8. 10.1080\/09273940902916111","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/296173-two-case-reports-of-zoledronic-acid-induced-acute-anterior-uveitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:03:40Z","timestamp":1730300620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/296173-two-case-reports-of-zoledronic-acid-induced-acute-anterior-uveitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.72689","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,30]]}}}